|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Fulcrum Therapeutics (NASDAQ: FULC) through any online brokerage.
The latest price target for Fulcrum Therapeutics (NASDAQ: FULC) was reported by HC Wainwright & Co. on August 17, 2021. The analyst firm set a price target for 40.00 expecting FULC to rise to within 12 months (a possible 150.16% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $15.99 last updated Today at 4:48:26 PM.
There are no upcoming dividends for Fulcrum Therapeutics.
Fulcrum Therapeutics’s $Q4 earnings are confirmed for after-market on March 3, 2022.
There is no upcoming split for Fulcrum Therapeutics.
Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.